Picture of Sino Biopharmaceutical logo

1177 Sino Biopharmaceutical Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareAdventurousLarge CapNeutral

Annual cashflow statement for Sino Biopharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
HKAS
HKAS
HKAS
HKAS
HKAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line5,5845,01318,5735,7795,410
Depreciation
Amortisation
Non-Cash Items-399-600-13,112566786
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-1,393-698-1,066-1,088-1,177
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities5,3255,3255,3666,2656,066
Capital Expenditures-1,449-1,424-1,714-1,243-1,068
Purchase of Fixed Assets
Other Investing Cash Flow Items-2,375-6,421-802-2,827311
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-3,824-7,846-2,516-4,071-757
Financing Cash Flow Items-1,512-1,725-452-2,014-3,766
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities2,8012,233-3,225-3,186-6,549
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash4,396-7.02-1,025-945-1,150